US 8636997
Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 8636997 (Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/7052